Trial Profile
Insulin glulisine has a faster onset of action compared with insulin aspart in healthy volunteers.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin glulisine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 05 Nov 2010 New trial record.